Ftse Mib
34.816,86
0,46%
DAX
18.740,06
-0,09%
S&P 500
5.221,88
-0,02%
NASDAQ
16.383,45
0,26%
Bitcoin
62.944,80
2,44%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Arch Therapeutics Inc (QB) (ARTHD) Arch Therapeutics Inc (QB) (ARTHD) Notizie

ARTHD

Arch Therapeutics (QB) (ARTHD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARTHD
DataOraFonteTitoloSimboloCompagnia
09/05/202422:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
06/05/202422:36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202422:30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
15/02/202422:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ARTHDArch Therapeutics Inc (QB)
22/01/202418:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
29/12/202322:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:ARTHDArch Therapeutics Inc (QB)
05/10/202323:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202323:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
01/09/202322:30Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
22/08/202322:52Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
09/08/202317:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:ARTHDArch Therapeutics Inc (QB)
22/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHDArch Therapeutics Inc (QB)
23/05/202312:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHDArch Therapeutics Inc (QB)
16/05/202312:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHDArch Therapeutics Inc (QB)
25/01/202321:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHDArch Therapeutics Inc (QB)
23/01/202323:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHDArch Therapeutics Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARTHD

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ISP
Intesa Sanpaolo
BIT
BFF
BFF Bank
BIT
LDO
Leonardo
BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
DIA
DiaSorin
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
SPM
Saipem
BIT
NEXI
Nexi S.p.A
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network